The Use of Bromocriptine for Peripartum Cardiomyopathy after Twin Delivery via Oocyte Donation

Peripartum cardiomyopathy (PPCM) is rare but life-threatening. We herein report the case of a 48-year-old woman with PPCM after oocyte donation and delivery of twins. Two weeks after delivery, she suffered from severe symptoms of heart failure [orthopnea, New York Heart Association (NYHA) class IV,...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Nagisa, Nakayoshi, Takaharu, Yoshimura, Hanae, Watanabe, Megumi, Kumanomido, Jun, Furusho, Aya, Fukui, Daisuke, Eto, Kazuko, Nishida, Norifumi, Nishihara, Michihide, A. Kamiya, Chizuko, Fukumoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421160/
https://www.ncbi.nlm.nih.gov/pubmed/30568125
http://dx.doi.org/10.2169/internalmedicine.1537-18
Descripción
Sumario:Peripartum cardiomyopathy (PPCM) is rare but life-threatening. We herein report the case of a 48-year-old woman with PPCM after oocyte donation and delivery of twins. Two weeks after delivery, she suffered from severe symptoms of heart failure [orthopnea, New York Heart Association (NYHA) class IV, pulmonary edema and a reduced left ventricular ejection fraction of 18%]. Although standard heart failure therapy was effective for diminishing the congestion, it was not sufficient to improve her symptoms or left ventricular systolic dysfunction. During admission, we added bromocriptine. A year later after the onset, she was in a good state with an improved left ventricular systolic function.

Ejemplares similares